Product Information
DOXYCYCLINE MONO 50 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1604 per EA under NDC 62135072520. Its NADAC has been published 134 times since Mar 13, 2024.
FDA first approved this application on Dec 20, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Chartwell RX LLCNDC
62135072520
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA091605FDA Approved
12/20/2011
TE Code
AB
On Market Since
5/1/2012
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 50 MG TABLET has been published 134 times since Mar 13, 2024, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1604 per EA |
|---|---|
| All-time high | $0.2529 (Apr 10, 2024) |
| All-time low | $0.1555 (May 22, 2024) |
| 52-week high | $0.1938 |
| 52-week low | $0.1604 |
| Median price | $0.1858 |
| Average price | $0.1836 |
| Largest weekly change | +42.8% (Aug 21, 2024) |
| Weeks tracked | 134 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 50 MG TABLET, manufactured by Chartwell RX LLC, is $0.1604 per EA (NDC 62135072520), effective Sep 30, 2026.
How has the price of DOXYCYCLINE MONO 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 50 MG TABLET has declined 28.7%. It has been tracked across 134 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 50 MG TABLET?
Since Mar 13, 2024, the NADAC for DOXYCYCLINE MONO 50 MG TABLET has ranged from a low of $0.1555 (May 22, 2024) to a high of $0.2529 (Apr 10, 2024), with a median of $0.1858 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 50 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE MONO 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE MONO 50 MG TABLET?
DOXYCYCLINE MONO 50 MG TABLET (NDC 62135072520) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.